• Assisting schizophrenia diagnosis using clinical electroencephalography and interpretable graph neural networks: a real-world and cross-site study
  Published on 2023-07-25
  2 years ago
• The orexin neurotransmitter system as a target for medication development for opioid use disorder
  Published on 2023-07-25
  2 years ago
• Functional connectivity of salience and affective networks among remitted depressed patients predicts episode recurrence
  Published on 2023-07-25
  2 years ago
• Correction to: Pathways link environmental and genetic factors with structural brain networks and psychopathology in youth
  Published on 2023-07-25
  2 years ago
• Puerarin attenuates valproate-induced features of ASD in male mice via regulating Slc7a11-dependent ferroptosis
  Published on 2023-07-25
  2 years ago
• Bayesian dynamical system analysis of the effects of methylphenidate in children with attention-deficit/hyperactivity disorder: a randomized trial
  Published on 2023-07-25
  2 years ago
• Disassociating drug active ingredients from inactive: ketamine-like synaptic effects of a ketamine excipient
  Published on 2023-07-24
  2 years ago

« Previous 1 … 89 90 91 92 93 … 143 Next »

• Cariprazine modulates sleep architecture in rats
  Published on 2021-01-07
  5 years ago
• Efficacy of N-methyl-D-aspartate receptor modulator augmentation in schizophrenia: A meta-analysis of randomised, placebo-controlled trials
  Published on 2021-01-07
  5 years ago
• Acute acetate administration increases endogenous opioid levels in the human brain: A [11C]carfentanil molecular imaging study
  Published on 2021-01-07
  5 years ago
• Pharmacotherapy of attention deficit/hyperactivity disorder in individuals with autism spectrum disorder: A systematic review of the literature
  Published on 2020-12-22
  5 years ago
• A comparison of MDMA-assisted psychotherapy to non-assisted psychotherapy in treatment-resistant PTSD: A systematic review and meta-analysis
  Published on 2020-12-21
  5 years ago
• Mystical-type experiences occasioned by ketamine mediate its impact on at-risk drinking: Results from a randomized, controlled trial
  Published on 2020-12-14
  5 years ago
• Dopaminergic neuromodulation has no detectable effect on visual-cue induced haemodynamic response function in the visual cortex: A double-blind, placebo-controlled functional magnetic resonance imaging study
  Published on 2020-12-14
  5 years ago

« Previous 1 … 89 90 91 92 93 … 134 Next »

• Emotional cognition subgroups in mood disorders: Associations with familial risk
  Published on 2021-06-05
  5 years ago
• Polygenic risk scores in psychiatry – Large potential but still limited clinical utility
  Published on 2021-06-04
  5 years ago
• Do cariprazine and brexpiprazole cause impulse control symptoms? A case/non-case study
  Published on 2021-06-01
  5 years ago
• Oxytocin blood concentrations in alcohol use disorder: A cross-sectional, longitudinal, and sex-separated study
  Published on 2021-05-31
  5 years ago
• There are no patients without comorbidity
  Published on 2021-05-31
  5 years ago
• Can we expect a rise in suicide rates after the Covid-19 pandemic outbreak?
  Published on 2021-05-30
  5 years ago
• Epidemiology and costs of depressive disorder in Spain: the EPICO study
  Published on 2021-05-29
  5 years ago

« Previous 1 … 89 90 91 92 93 … 154 Next »